Is it coincidental that enactment of ObamaCare recently resulted in revised government recommendations for medical testing? If not for cost, why are long-standing testing procedures suddenly being questioned? Could it be the “Affordable Care Act” or ObamaCare, may not be so affordable after all? Are government sponsored agencies attempting to influence physicians, medical facilities and patients to limit testing because of cost?

The answers to these questions rest on the fact ObamaCare will require government responsibility for millions more on Medicaid and Medicare rolls including previously uninsured, the Baby Boomer generation and illegal aliens.

For years, medical experts hailed the benefits of testing for breast cancer. Women were implored by doctors and the National Cancer Institute to have periodic mammograms commencing at age 40 and every two years thereafter. Suddenly, this test that provides early detection and treatment, if necessary, is being questioned.

Until recently, men were encouraged to test for prostate cancer. Most doctors and the U.S. Food and Drug Administration (FDA) recommended use of the PSA test in addition to a digital rectal exam (DRE). Men over 50 and those with family history of prostate cancer, were advised to participate. This, too, is suddenly under fire.

Now, The U.S. Preventative Services Task Force is questioning whether we should continue using electrocardiograms (EKG) to test for coronary heart disease. Its time for the American Medical Association to clarify whether these recommendations are genuine or simply Obamacare propaganda.